Investigation: bd received photos from the customer facility for investigation.The photos were evaluated, and the customer's indicated failure mode for inability to activate safety shield was observed.A review of the device history record was completed for the incident lot and, based on this review, all product specifications and requirements for lot release were met; there were no related quality non-conformances during manufacturing of the product.Bd has initiated further investigation relating to this issue through a capa and potential causes from the manufacturing process have been identified.As a result, corrective actions have been established and are in the process of being implemented.Based on evaluation of the photos, the customer¿s indicated failure mode for inability to activate safety shield with the incident lot was observed.Further investigation activities have been conducted relating to this product issue and possible root causes from the manufacturing process have been identified.As a result, corrective actions and procedures are being implemented to mitigate further occurrences.Bd has initiated further investigation through a capa.The investigation has identified possible root causes from the manufacturing process and corrective actions are in the process of being implemented.
|
It was reported that the needle shield of a bd eclipse¿ blood collection needle with luer adapter failed, after use.It was reported that the needle ¿ended up bending resulting in a needle stick injury¿, which they reported to ¿the needlestick exposure line¿.No additional interventions were reported.
|